Welterman International Limited is an Indian industrial entity specializing in the manufacture and distribution of **inorganic water-soluble chemical fertilizers**. The company’s primary product is **Magnesium Sulphate** (Epsom Salt), a versatile mineral serving the agriculture, pharmaceutical, and personal care sectors. Following a strategic relocation in **2023**, the company is currently focused on stabilizing its operations through trading and marketing activities while navigating a period of financial transition. --- ### **Strategic Relocation and Operational Footprint** In **May 2023**, the company executed a significant strategic shift by moving its registered office and primary base of operations from **Gujarat to Maharashtra**. This move was intended to enhance the company’s industrial footprint and align with long-term growth objectives. * **New Manufacturing Base:** Located at **MIDC Industrial Area, Dhatav, Roha (Maharashtra)**. * **Corporate Identity:** Following the move, the company’s **Corporate Identification Number (CIN)** was updated to **L51100MH1992PLC408530**. * **Market Concentration:** Currently, the company operates exclusively within the **Domestic Market**. For the most recent fiscal period, the company reported **zero overseas revenue**. --- ### **Core Product Portfolio: Magnesium Sulphate Applications** The company’s business model revolves around the production of **Magnesium Sulphate**, both as a naturally occurring mineral and through synthetic production (reacting **sulphuric acid** with **magnesium and oxides**). This allows the company to meet high-purity standards for diverse industrial applications: | Industry Segment | Primary Application & Utility | | :--- | :--- | | **Agriculture** | Critical **fertilizer** for plant nutrition; essential for crop development and high-yield farming. | | **Personal Care** | Basic ingredient in consumer care formulations; identified as the **highest growth rate** segment. | | **Food & Beverage** | Used as a **flavour enhancer** and in **feedstock** to meet rising global caloric demands. | | **Pharmaceuticals** | Utilized in medicinal supplements and human health formulations. | --- ### **Financial Performance and Capital Structure** Welterman International is currently managing a period of financial contraction, characterized by declining revenues and accumulated losses. Consequently, the Board has not recommended any **dividend** payments for the fiscal year ending **March 31, 2025**. **Three-Year Financial Summary:** | Financial Year | Total Income (₹ Lakhs) | Net Profit / (Loss) (₹ Lakhs) | | :--- | :--- | :--- | | **2024-25** | **20.41** | **(15.51)** | | **2023-24** | **20.43** | **(13.28)** | | **2022-23** | **84.45** | **(29.98)** | **Capital and Reserves:** * **Paid-up Equity Share Capital:** Stable at **₹ 4,44,13,000** (comprising **4,44,13,000** shares). * **Reserves:** No amounts were transferred to the **General Reserve** due to net losses. * **Securities:** The company has issued no **Sweat Equity**, **ESOPs**, or **Differential Rights** shares under the 2014 Rules. * **Vendor Relations:** The company maintains a strict policy of no overdue payments to **MSME vendors**, adhering to all contractual terms. --- ### **Market Drivers and Growth Strategy** The company’s strategy is built on leveraging technological advancements and favorable government policies to capture the rising demand for specialized agricultural inputs. * **Agricultural Modernization:** Growth is driven by the adoption of **water-soluble and liquid fertilizers** and the expansion of **micro-irrigation** systems. * **Food Security Trends:** The **WHO** projects global consumption will reach **3,050 Kcal** per capita per day by **2030**, increasing the "tremendous pressure" for high-quality food production and, by extension, nutrient-based fertilizers. * **Consumer Innovation:** The company is targeting the **Personal Care** sector for diversification, anticipating high demand for customized Magnesium Sulphate formulations. * **Leadership Stability:** **Mr. Mohammed Mansur H. Dhanani** has been reappointed as **Director and CEO** for a **5-year term** effective **July 30, 2025**, ensuring management continuity. --- ### **Risk Profile and Regulatory Challenges** Investors should note several significant risks that impact the company’s valuation and operational stability. **1. Regulatory and FEMA Compliance:** The company has an outstanding payable of **USD 456,001.38** (approx. **₹ 3.90 Crores**) to a **Related Party** that has been unpaid for over **three years**. This poses a potential risk under the **Foreign Exchange Management Act, 1999 (FEMA)**, with uncertain implications regarding penalties or interest. **2. Operational Stagnation:** Auditors have noted a lack of **significant operational activity** in recent years. Current efforts are primarily focused on sustenance and trading rather than large-scale manufacturing expansion. **3. Foreign Currency Sensitivity:** The company maintains **unhedged foreign currency exposures**. A **5% fluctuation** in the **USD/INR** exchange rate significantly impacts the bottom line: | Particulars (₹ in Lakhs) | FY 2024-25 (5% Change) | FY 2023-24 (5% Change) | | :--- | :--- | :--- | | **Impact of 5% USD Increase** | **(19.51)** | **(19.01)** | | **Impact of 5% USD Decrease** | **19.51** | **19.01** | **4. Macroeconomic and Geopolitical Threats:** * **Supply Chain:** The **Russia-Ukraine War** and other geopolitical tensions threaten to increase **tariff rates** and disrupt the availability of raw materials. * **Cost Pressures:** Rising inflation and input costs, combined with intense competition from lower-priced providers, continue to squeeze profit margins. --- ### **Governance and Oversight** To strengthen corporate governance during its transition, the company has appointed specialized firms for audit functions: * **Secretarial Auditors:** **M/s Devesh Pathak & Associates** (5-year tenure, FY 2025-26 to 2029-30). * **Internal Auditors:** **M/s Jwalant Shah & Associates** (for FY 2025-26).